Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed) – Scholarship and Grants Opportunities

    0
    313

    Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed)

    Funding Opportunity ID: 310581
    Opportunity Number: PA-19-076
    Opportunity Title: Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed)
    Opportunity Category: Discretionary
    Opportunity Category Explanation:
    Funding Instrument Type: Grant
    Category of Funding Activity: Health
    Category Explanation:
    CFDA Number(s): 93.121
    Eligible Applicants: Small businesses
    Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
    Agency Code: HHS-NIH11
    Agency Name: Department of Health and Human Services
    National Institutes of Health
    Posted Date: Nov 26, 2018
    Close Date: Jan 05, 2022
    Last Updated Date: Nov 26, 2018
    Award Ceiling: $0
    Award Floor: $0
    Estimated Total Program Funding:
    Expected Number of Awards:
    Description: Purpose This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices to clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and clinical outcome assessment. Areas of interest in this FOA include engineering approaches that allow integration of electronic, physical, and biological systems essential to the development of functional biodevices that are safe and effective for detection, diagnosis and treatment of oral and systemic disease. Products of this research will be proof-of-concept prototype biodevices, dedicated biosensors, associated core technologies and integrated approaches that enable development of safe and effective intra-oral biodevices intended for specific clinical applications. To streamline the development of oral biodevices that advance precision medicine-based approaches in clinical practice, this FOA encourages interdisciplinary collaborations across engineering, multifunctional sensors, pharmacology, chemistry, medicine, and dentistry, as well as between academia and industry.
    Version: 1
    Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here